$NWE

NorthWestern Energy's resource plan gets criticisms for ignoring data centers

NorthWestern Energy’s 20-year Integrated Resource Plan for Montana is facing criticism from a coalition of advocacy groups and the public, who say it underweights renewables and does not adequately account for data centers’ impact on electricity costs. The Montana Public Service Commission plans to review it in mid-August and can identify deficiencies. The groups cite a University of Michigan study and question fossil fuel and battery limits.

Original reporting
Published Aug 5, 2026, 11:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 12:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefRegulation
Primary signal
$NWE
Bearish
medium confidence
Mentioned
$NWE
Relevance
6/10
AlphAI data visualization · based on glasgowcourier.com
Decision brief

The 30-second read

$NWEBearishMed
01

Why it matters

Public advocacy groups argue the plan inadequately addresses climate change and data-center-driven cost impacts, and they cite alleged forecast and disclosure gaps. PSC leadership indicates the plan will be taken up in mid-August, with the agency able to identify deficiencies.

02

Market read

This is a regulatory-process catalyst for NWE’s planning assumptions, with potential implications for future rate-base and resource mix if PSC identifies deficiencies.

03

What to watch

The article does not quantify how PSC findings would alter NWE’s capital plan or rates; the pending Black Hills merger outcome may be the larger driver of future resource adequacy than the IRP criticisms alone.

Relevance 6/10Novelty 5/10Timing: PSC plans to take up NWE’s IRP in mid-August

Background

Montana Public Service Commission is reviewing NorthWestern Energy’s Integrated Resource Plan covering the next 20 years.

Company-level read

Ticker impact

$NWEBearishMedium confidence
Context

NorthWestern Energy’s 20-year Integrated Resource Plan faces criticism at Montana PSC hearings for allegedly undercounting data-center demand and climate impacts.

Expected impact

Near-term: modest downside bias from regulatory overhang; longer-term: risk to cost-of-service and resource planning if PSC identifies deficiencies.

Evidence & confidence

The article describes a pending PSC review in mid-August and alleges deficiencies including insufficient climate treatment, capped battery storage, and failure to account for a proposed Black Hills merger.

Market effects

Highlights regulatory and political risk for US utilities’ data-center load growth assumptions and clean-energy planning constraints (battery caps, fossil fuel reliance).

Montana PSC process and potential consumer-protection legislation could affect how utilities allocate costs to data-center customers.

Limited direct global impact, but reinforces broader power-planning scrutiny tied to AI/data-center demand and decarbonization commitments.

Counterpoint

PSC cannot approve or reject the IRP, only identify deficiencies, so the immediate financial impact on NWE may be limited unless deficiencies translate into enforceable changes.

Key entities

  • NorthWestern Energy

    Montana utility whose 2026 Integrated Resource Plan is under criticism for climate and data-center demand assumptions.

  • Montana Public Service Commission

    State agency reviewing the IRP and expected to take it up in mid-August.

  • Earthjustice

    Filed a 134-page review raising concerns including battery storage caps and failure to account for a proposed Black Hills merger.

  • Black Hills Corp

    Proposed merger partner mentioned as potentially affecting NWE’s load forecasts and resource adequacy.

Related articles

$NWEMedAI 8/10

NorthWestern Energy Group, Inc. (NWE): Results of Operations and Financial Condition

NorthWestern Energy Group, Inc. (NWE) filed an SEC Form 8-K — Results of Operations and Financial Condition. NorthWestern Energy Group, Inc. d/b/a NorthWestern Energy 3010 W. 69 th Street Sioux Falls, SD 57108 www.northwesternenergy.com FOR IMMEDIATE RELEASE NorthWestern Energy Reports Second Quarter 2026 Financial Results • Second Quarter 2026 Diluted GAAP EPS of $0.40, compared to $0.

$BKHLow

BofA Sees Strategic Value in Black Hills (BKH)-NorthWestern (NWE) Combination

Bank of America upgraded Black Hills Corp. (BKH) to Buy from Neutral and raised its price target to $78 from $76, citing expectations that BKH’s pending all-stock merger with NorthWestern Energy (NWE) will close. The bank said the deal could add scale, a stronger balance sheet, broader diversification, and more infrastructure opportunities, including Wyoming data centers and the Jade project.

$COINHigh

The SEC Steps In to Ease Crypto’s Path After Big Legislative Loss

The SEC introduced a five-year exemption to securities laws to enable trading of tokenized stocks, following Congress' failure to pass the Clarity Act. This move aims to support digital assets and follows a 48-hour turnaround. Bitcoin and crypto-linked stocks like Coinbase (COIN), Robinhood (HOOD), and Circle (CRCL) saw gains.

$RAREHighAI 9/10

Ultragenyx stock surges 10% on FDA approval for gene therapy

Ultragenyx Pharmaceutical (RARE) shares rose 10% after the FDA approved Fayuvi, a gene therapy for mucopolysaccharidosis type IIIA. This is the first FDA-authorized treatment for this rare pediatric disease. The therapy showed improved cognitive function in clinical trials but carries risks like liver enzyme increases and potential long-term tumor development.

$AZNMed

AstraZeneca Gains as Enhertu Clears England's Value Gate

AstraZeneca's Enhertu gained NHS approval in England for HER2-low metastatic breast cancer treatment, reversing a prior rejection. The company's shares rose 1.3% to $165.04. The drug's cost-effectiveness was not disclosed, but it extends survival by around six months. This approval may expand access in Wales and Northern Ireland, potentially boosting AstraZeneca's revenue.